Ken Griffin Immunome Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Immunome Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 28,100 shares of IMNM stock, worth $436,674. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,100
Previous 21,400
31.31%
Holding current value
$436,674
Previous $528,000
35.61%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IMNM
# of Institutions
115Shares Held
43.4MCall Options Held
67.2KPut Options Held
65.9K-
Redmile Group, LLC San Francisco, CA4.89MShares$76 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$60.3 Million1.66% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$60.3 Million0.03% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$58.4 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.16MShares$49.2 Million0.02% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $188M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...